Bristol-Myers Squibb Co/ US1101221083 /
| 2024-07-26 9:59:56 PM | Chg. +5.18 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 50.45USD | +11.44% | 1.06 mill. Turnover: 52.67 mill. |
-Bid Size: - | -Ask Size: - | 102.27 bill.USD | 4.58% | 13.00 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 3.88 USD | 30.64% |
| EPS Diluted: | 3.86 USD | 30.85% |
| Revenues per Share: | 22.26 USD | 1.19% |
| Book Value per Share: | 14.58 USD | -1.66% |
| Cash Flow per Share: | 6.85 USD | 10.09% |
| Dividend per Share: | 2.31 USD | 5.48% |
| Total | in mill. | |
| Revenues: | 45,006.00 USD | -2.50% |
| Net Income: | 8,025.00 USD | 26.84% |
| Operating Cash Flow: | 13,860.00 USD | - |
| Cash and Cash Equivalents: | 11,464.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 13.00 | 13.22 |
| P/S Ratio: | 2.27 | 2.31 |
| P/BV ratio: | 3.46 | 3.52 |
| P/CF Ratio: | 7.36 | 7.49 |
| PEG: | 0.42 | 0.43 |
| Earnings Yield: | 7.69% | 7.56% |
| Dividend Yield: | 4.58% | 4.50% |
| Market Capitalization | ||
| Market Capitalization: | 102.27 bill. USD | 103.76 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 2.03 bill. | |
Profitability
| Gross Profit Margin: | 76.24% |
| EBIT Margin: | 0.00% |
| Net Profit Margin: | 17.83% |
| Return on Equity: | 27.22% |
| Return on Assets: | 8.43% |
Financial Strength
| Liquidity I / Cash Ratio: | 51.50% |
| Liquidity II / Quick Ratio: | 100.55% |
| Liquidity III / Current Ratio: | 142.71% |
| Debt / Equity Ratio: | 222.74% |
| Dynam. Debt / Equity Ratio: | 473.84% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
